Publications

Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves.

Lindsey, BB; Villabona-Arenas, CJ; Campbell, F; KEELEY, AJ; Parker, MD; Shah, DR; Parsons, H; Zhang, P; Kakkar, N; Gallis, M; Foulkes, BH; Wolverson, P; Louka, SF; Christou, S; State, A; Johnson, K; Raza, M; Hsu, S; JOMBART, T; Cori, A; Sheffield COVID-19 Genomics Group,; COVID-19 Genomics UK (COG-UK) consortium,; CMMID COVID-19 working group,; Evans, CM; Partridge, DG; ... De Silva, TI.

2022

Nature communications, (2022).13 1 10.1038/s41467-022-28291-y.

How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases.

Clark, J; Stolk, WA; Basáñez, M-G; Coffeng, LE; Cucunubá, ZM; Dixon, MA; Dyson, L; Hampson, K; MARKS, M; MEDLEY, GF; Pollington, TM; Prada, JM; Rock, KS; Salje, H; Toor, J; Hollingsworth, TD;

2022

Gates open research, (2022).5, 10.12688/gatesopenres.13327.2.

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India.

Harris, RC; QUAIFE, M; WEERASURIYA, C; Gomez, GB; SUMNER, T; BOZZANI, F; WHITE, RG;

2022

Nature Communications, (2022).13 1 10.1038/s41467-022-28234-7.

Public perceptions and interactions with UK COVID-19 Test, Trace and Isolate policies, and implications for pandemic infectious disease modelling.

Marshall, G; Skeva, R; Jay, C; Silva, M; Fyles, M; House, T; Davis, E; Pi, L; MEDLEY, G; Quilty, B; Dyson, L; Yardley, L; FEARON, E;

2022

medRxiv (2022). 10.1101/2022.01.31.22269871.

Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.

Krieger, E; Kudryavtsev, A; Sharashova, E; Postoev, V; Belova, N; Shagrov, L; Zvedina, J; Drapkina, O; Kontsevaya, A; Shalnova, S; Brenn, T; Shkolnikov, VM; EGGO, RM; LEON, DA;

2022

EMERGING INFECTIOUS DISEASES, (2022).28 2 10.3201/eid2802.211640.

Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY.

OpenSAFELY Collaborative,; Fisher, L; Speed, V; Curtis, HJ; RENTSCH, CT; WONG, AY S; SCHULTZE, A; Massey, J; Inglesby, P; Morton, CE; Wood, M; Walker, AJ; Morley, J; Mehrkar, A; Bacon, S; Hickman, G; Bates, C; Croker, R; Evans, D; Ward, T; Cockburn, J; Davy, S; BHASKARAN, K; Smith, B; WILLIAMSON, E; ... GOLDACRE, B.

2022

THROMBOSIS RESEARCH, (2022).211, 10.1016/j.thromres.2022.01.023.

Triadic partnerships: Evaluation of a group mentorship scheme.

FOSS, AM; Kohler, S; Kulkarni, S; Sutton, N; Schreiner, M-A; Centemero, NS; Mambula, G; Lohman, D; SMITH, SC; FRENCH, R;

2022

International Journal for Students as Partners, (2022).6 1 10.15173/ijsap.v6i1.4858.

gwenknight/strain_growth.

KNIGHT, G; Baede, VO;

2022

, Github (2022).

Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.

BHASKARAN, K; RENTSCH, CT; Hickman, G; Hulme, WJ; SCHULTZE, A; Curtis, HJ; WING, K; WARREN-GASH, C; TOMLINSON, L; Bates, CJ; MATHUR, R; MacKenna, B; MAHALINGASIVAM, V; WONG, A; Walker, AJ; Morton, CE; GRINT, D; Mehrkar, A; EGGO, RM; Inglesby, P; DOUGLAS, IJ; MCDONALD, HI; Cockburn, J; WILLIAMSON, EJ; Evans, D; ... GOLDACRE, B.

2022

PLoS medicine, (2022).19 1 10.1371/journal.pmed.1003871.

A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial.

MACKENZIE, GA; OSEI, I; Salaudeen, R; Hossain, I; Young, B; Secka, O; D'ALESSANDRO, U; Palmu, AA; Jokinen, J; Hinds, J; FLASCHE, S; Mulholland, K; Nguyen, C; GREENWOOD, B;

2022

Trials, (2022).23 1 10.1186/s13063-021-05964-5.